Description: ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, and bladder cancer. In addition, the company offers continence care products and services for people with urinary continence issues related to spinal cord injuries, multiple sclerosis, spina bifida, and other causes, as well as critical care devices and products used in intensive care units and hospital settings. Further, it provides infusion care solutions comprising disposable infusion sets for diabetes insulin pumps, or for pumps used in continuous subcutaneous infusion treatments for conditions such as parkinson's disease. The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers. It serves a range of customers, including healthcare providers, patients, and manufacturers. ConvaTec Group PLC was founded in 1978 and is headquartered in London, the United Kingdom.
Home Page: www.convatecgroup.com
20 Eastbourne Terrace
London,
W2 6LG
United Kingdom
Phone:
44 11 8952 8100
Officers
| Name | Title |
|---|---|
| Mr. Karim Bitar | CEO & Director |
| Mr. Jonathan Peter Mason | Group CFO & Director |
| Mr. John Haller | Executive VP and Chief Quality & Operations Officer |
| Dr. Divakar Ramakrishnan Ph.D. | Executive VP, Chief Technology Officer and Head of Research & Development |
| Ms. Kate Postans | Vice President of Investor Relations & Corporate Communications |
| Ms. Evelyn Douglas J.D. | Executive VP, Chief of Corporate Strategy & Business Development and General Counsel |
| Ms. Moyra Withycombe | Interim Chief People Officer |
| Ms. Kjersti Grimsrud Biotechnology, M.Sc. | President & COO of Infusion Care |
| Mr. David Shepherd | President & COO of Global Advanced Wound Care |
| Mr. Seth R. Segel | President and COO of Continence Care & Home Services Group |
Exchange: F
Country: DE : Germany
Currency: Euro (€)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Health Care Equipment & Services |
| GIC Industry: | Health Care Equipment & Supplies |
| GIC Sub-Industry: | Health Care Equipment |
| Forward PE: | 16.4474 |
|---|---|
| Trailing PE: | 39.6429 |
| Price-to-Book MRQ: | 3.6313 |
| Price-to-Sales TTM: | 2.5994 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 10000 |